Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03571724 · ClinicalTrials.gov registry record · NA

A Study to Assess Changes in Cigarette Consumption During a Switch to Very Low Nicotine Cigarettes

A NA study, sponsored by 22nd Century Group.

Completed
Registry status
NA
Development phase
142
Enrollment target

NCT03571724: Completed NA study, sponsored by 22nd Century Group.

NCT03571724 is a NA study that has completed, run by 22nd Century Group. The registered enrollment target is 142 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03571724, a NA study, has completed, sponsored by 22nd Century Group.

COMPLETED
Registry status
NA
Development phase
142 participants
Enrollment target

Study Summary

This study evaluates the impact of switching from usual brand cigarettes to very low nicotine cigarettes on cigarette consumption, smoking behavior, and biomarkers of exposure.

Interventions

  • OTHER Non-Menthol Very Low Nicotine Cigarettes
  • OTHER Menthol Very Low Nicotine Cigarettes
  • OTHER Subject's UB non-mentholated filtered cigarettes
  • OTHER Subject's UB mentholated filtered cigarettes

Trial Details

FieldValue
Enrollment Target 142 participants
Start Date 2018-06-28
Est. Completion 2019-03-08
Phase NA

Sponsor

22nd Century Group

3 total trials

What the Registry Record Tells You About NCT03571724

The ClinicalTrials.gov registry entry for NCT03571724 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The listed sponsor is 22nd Century Group, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Non-Menthol Very Low Nicotine Cigarettes is the first listed.

NCT03571724 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03571724 about?

NCT03571724 is a clinical study titled "A Study to Assess Changes in Cigarette Consumption During a Switch to Very Low Nicotine Cigarettes". This study evaluates the impact of switching from usual brand cigarettes to very low nicotine cigarettes on cigarette consumption, smoking behavior, and biomarkers of exposure.

What is the current status of trial NCT03571724?

This trial is currently completed. It is a NA study. The enrollment target is 142 participants. The study started on 2018-06-28. Estimated completion is 2019-03-08.

What interventions are being tested in trial NCT03571724?

The interventions under investigation include: Non-Menthol Very Low Nicotine Cigarettes (OTHER), Menthol Very Low Nicotine Cigarettes (OTHER), Subject's UB non-mentholated filtered cigarettes (OTHER), Subject's UB mentholated filtered cigarettes (OTHER).

Who is sponsoring clinical trial NCT03571724?

This trial is sponsored by 22nd Century Group, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.